Experimental Study on Sustained-release 5-Fluorouracil Implantation in Canine Peritoneum and Para-aortic Abdominalis |
Wei, Guo
(Department of General Surgery, Changhai Hospital Affiliated to The Second Military Medical University)
Nie, Ming-Ming (Department of General Surgery, Changhai Hospital Affiliated to The Second Military Medical University) Shen, Xiao-Jun (Department of General Surgery, Changhai Hospital Affiliated to The Second Military Medical University) Xue, Xu-Chao (Department of General Surgery, Changhai Hospital Affiliated to The Second Military Medical University) Ma, Li-Ye (Department of General Surgery, Changhai Hospital Affiliated to The Second Military Medical University) Du, Cheng-Hui (Department of General Surgery, Changhai Hospital Affiliated to The Second Military Medical University) Wang, Shi-Liang (Controlled-Release Drug Laboratory, Hefei University of Technology) Bi, Jian-Wei (Controlled-Release Drug Laboratory, Hefei University of Technology) |
1 | Hu XF, Yao J, Gao SG, et al (2013). Nrf2 overexpression predicts prognosis and 5-fu resistance in gastric cancer. Asian Pac J Cancer Prev, 14, 5231-5. 과학기술학회마을 DOI ScienceOn |
2 | Alexander HR Jr, Bartlett DL, Pingpank JF, et al (2013). Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery, 153, 779-86. DOI ScienceOn |
3 | Chen WP, He X, Ye QF, et al (2006). Implantation of a drug delivery system during surgery for patients with primary hepatocarcinoma. Hepatobiliary Pancreat Dis Int, 5, 391-5. |
4 | Davis JL, Pandalai P, Ripley RT, et al (2011). Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial. Trials, 12, 129. DOI |
5 | Oshima T, Shan J, Okugawa T, et al (2013). Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front. PLoS One, 8, e74757. DOI |
6 | Muchmore JH, Preslan JE, George WJ (1996). Regional chemotherapy for inoperable pancreatic carcinoma. Cancer, 78, 664-73. DOI |
7 | Nordlinger B, Rougier P, Arnaud JP, et al (2005). Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial. Lancet Oncol, 6, 459-68. DOI ScienceOn |
8 | Orii T, Karasawa Y, Kitahara H, et al (2013). Long-term survival after sequential chemotherapy and surgery for advanced gastric cancer. Int J Surg Case Rep, 4, 976-80. DOI ScienceOn |
9 | Pohlen U, Rieger H, Kunick-Pohlen S, et al (2007). Phase II study of regional chemotherapy using the hypoxic abdominal perfusion technique in advanced abdominal carcinoma. 5-FU pharmacokinetics, complications and outcome. Anticancer Res, 27, 667-74. |
10 | Wan NB, Zhang L, Zuo CH, et al (2012). Clinical application of intrapertoneal hyperthermo-chemotherapy combined with sustained-release fluorouracil implantation in progressive gastric cancer during surgery. J Chin Phys, 14, 763-6. |
11 | Zhang X, Zhu H, Wu X, et al (2013). A genetic polymorphism in TOX3 is associated with survival of gastric cancer in a Chinese population. PLoS One, 8, e72186. DOI |
12 | Wang R, Wang ZC, Liu XY, et al (2012). An experimental study on local and systemic reactions after sustained-release fluorouracil implantation. Shandong Med J, 14, 763-6. |
13 | Wang X, Song ZF, Xie RM, et al (2013). Analysis of death causes of in-patients with malignant tumors in Sichuan Cancer Hospital of China from 2002 to 2012. Asian Pac J Cancer Prev, 14, 4399-402. 과학기술학회마을 DOI ScienceOn |
14 | Halhsscy MT, Dunn JA, Ward LC, et al (1994). The second British stomach cancer group trial of adjuvant radiotherapy or chemotherapy in rescetable gastric cancer: five year follow-up. Lancet, 343, 1309-12. DOI ScienceOn |
15 | Zare A, Mahmoodi M, Mohammad K, et al (2013). Survival analysis of patients with gastric cancer undergoing surgery at the Iran cancer institute: a method based on multi-state models. Asian Pac J Cancer Prev, 14, 6369-73. DOI ScienceOn |
16 | Zhang M, Li Z, Zhao B, et al (2011). Predictors of longterm survival in large gastric carcinoma patients. Hepatogastroenterology, 58, 2162-5. |
17 | Zhang M, Zhang H, Ma Y, et al. Prognosis and surgical treatment of gastric cancer invading adjacent organs. ANZ J Surg, 80, 510-4. |
18 | Zhou J, Zhou ZP, Cheng S, et al (2008). Clinical research on hypotonic intrapertoneal hyperthermo-chemotherapy combined with fibrin glue sustained-release fluorouracil implantation in progressive gastric cancer during surgery. Chin Arch Gen Surg, 4, 35-7. |
19 | Jarnagin WR, Schwartz LH, Gultekin DH, et al (2009). Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trialand assessment of DCE-MRI as a biomarker of survival. Ann Oncol, 20, 1589-95. DOI ScienceOn |
20 | Huang B, Sun Z, Wang Z, et al (2013). Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database. BMC Cancer, 4, 13-57. |
21 | Kirchhoff T, Zender L, Merkesdal S, et al (2005). Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver. World J Gastroenterol, 11, 1091-5. DOI |
22 | Link KH, Gansauge F, Gorich J, et al (1997). Palliative and adjuvant regional chemotherapy in pancreatic cancer. Eur J Surg Oncol, 23, 409-14. DOI ScienceOn |
23 | Wei GL, Huang XE, Huo JG, et al (2013). Phase II study on pemetrexed-based chemotherapy in treating patients with metastatic gastric cancer not responding to prior palliative chemotherapy. Asian Pac J Cancer Prev, 14, 2703-6. 과학기술학회마을 DOI ScienceOn |
24 | Yamamoto M, Baba H, Kakeji Y, et al (2004). Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer. Oncology, 67, 19-26. DOI ScienceOn |
25 | Yao Z, Guo H, Yuan Y, et al (2013). Retrospective analysis of docetaxel, oxaliplatin plus fluorouracil compared with epirubicin, cisplatin and fluorouracil as firstline therapy for advanced gastric cancer. J Chemother, 9, 341-9. |
26 | Yoney A, Isikli L (2013). Can capecitabine be used instead of concurrent bolus 5-FU in postoperative chemoradiotherapy for gastric adenocarcinoma? Asian Pac J Cancer Prev, 14, 5127-31. DOI ScienceOn |
27 | Yoshimura F, Inaba K, Kawamura Y, et al (2011). Clinical outcome and clinicopathological characteristics of recurrence after laparoscopic gastrectomy for advanced gastric cancer. Digestion, 83, 184-90. DOI ScienceOn |
![]() |